ACCEL Lite: Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL-Cholesterol
1 tracks • 0 plays • 0 favorites
ACCEL Lite: Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL-Cholesterol
Sid'Ahmed Abdelahi
0:0010:27
Success & Inspiration
Episodes
1
ACCEL Lite: Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL-Cholesterol
Sid'Ahmed Abdelahi